# Hanson Gifford

> Hanson Gifford is a Series B investor at Lightstone Ventures backing Wellness. See 1 investment, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Lightstone Ventures](https://shizune.co/investors/profile/lightstone-ventures)
- Location: Menlo Park, United States
- Total investments: 1
- Last investment: Aug 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/hanson-gifford-3bb5a37
- Facebook: https://www.facebook.com/hanson.gifford

Hanson Gifford is a Series B investor at Lightstone Ventures in Menlo Park focused on Wellness and Health Care. Hanson Gifford is the CEO and Managing Partner of The Foundry. He previously worked at Allay Therapeutics as a Co-Founder, Board Member. Hanson Gifford attended Cornell University.

## Contacts

5 contacts available for Hanson Gifford: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/hanson-gifford?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Wellness | 1 | 100% |
| Health Care | 1 | 100% |
| Medical Device | 1 | 100% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Reprieve Cardiovascular | Reprieve Cardiovascular is a pioneering medical device company focused on innovative fluid management technologies for congestive heart failure. The company's Reprieve technology is being investigated as an innovative fluid management treatment. Providing clinicians with the ability to precisely control a patient’s fluid volume may both enableimproved cardiac care, as well as, be instrumental in the decongestion of acutely decompensated heart failure patients (ADHF). Reprieve Cardiovascular, Inc. and RenalGuard Solutions, Inc. are subsidiaries of parent company CardioRenal Systems, Inc. | $61M | Series B | Aug 13, 2025 | https://reprievecardio.com/ |

1 of 1 investments shown.

## Co-investors
- [Arboretum Ventures](https://shizune.co/investors/profile/arboretum-ventures) — VC Fund, 1 deal together
- [Cadence Healthcare Ventures](https://shizune.co/investors/profile/cadence-healthcare-ventures) — VC Fund, 1 deal together
- [Deerfield Management](https://shizune.co/investors/profile/deerfield-management-4e45) — VC Fund, 1 deal together
- [Genesis Capital](https://shizune.co/investors/profile/genesis-capital) — VC Fund, 1 deal together
- [Rex Health Ventures](https://shizune.co/investors/profile/rex-health-ventures) — VC Fund, 1 deal together
- [Sante Ventures](https://shizune.co/investors/profile/sante-ventures) — VC Fund, 1 deal together

## About Lightstone Ventures

VC Fund · Menlo Park, United States

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.

5 contacts available at Lightstone Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Caroline Gaynor | Principal | https://shizune.co/investors/profile/caroline-gaynor |
| Christina Isacson | Partner | https://shizune.co/investors/profile/christina-isacson |
| Christopher M. Owens | Founder, President & CEO | https://shizune.co/investors/profile/christopher-m-owens |
| Christopher M. Owens | Founder, President & CEO | https://shizune.co/investors/profile/christopher-m-owens-b904 |
| Hank Plain | Partner | https://shizune.co/investors/profile/hank-plain |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Hanson Gifford invest in?

Hanson Gifford invests primarily in Wellness, Health Care and Medical Device startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Hanson Gifford?

Public channels for Hanson Gifford include LinkedIn and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Hanson Gifford last invest?

The most recent investment recorded for Hanson Gifford closed in Aug 2025. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co